Study Finds Measles Vaccine Far More Likely to Fail in C-Section Babies
According to a new study published in Nature Microbiology, babies born via Caesarean section (C-section) are likely to fail to respond to one dose of the live attenuated MMR (measles, mumps, rubella) vaccine. In fact, researchers found it is 2.6 times more likely that the vaccine is ineffective for babies who are born via C-section […]
Moderna Stops mRNA COVID Biologics Plant Construction in Kenya
Moderna, Inc. announced recently that it has suspended its efforts to build a $200–$500 million mRNA (messenger ribonucleic acid) biologics manufacturing facility in Kenya while it determines projected future demand for mRNA biologics in Africa. Company officials concluded that, since the end of the COVID pandemic, interest in COVID-19 biologics in Kenya and Africa has […]
Sperm Samples in French Infertility Clinic Have High Levels of Glyphosate
A recent study published in The Journal of Ecotoxicology and Environmental Safety last month revealed that more than half of the sperm samples collected from the Pole Santé Leonard de Vinci infertility clinic near Tours, France contained high levels of glyphosate—the primary ingredient in Bayer AG’s Roundup weed killer, which was developed and formerly marketed […]
Measles Outbreak in Chicago Migrant Shelter Reveals at Least 28 Percent Were Vaccinated
Following identification of 15 cases of measles in a Chicago shelter that houses migrants from Venezuela, city public health officials announced on Mar. 20, 2024 that “measles is circulating in our city. And it’s why we are putting a call out for everyone who is at risk to protect themselves now” by getting a measles-mumps-rubella […]
Birth Rates Hit Historic Low in U.S.
Birth rates in the United States hit a historic low last year according to data from the U.S. Centers of Disease Control and Prevention (CDC), and experts say there is evidence that the cause of this decline is not simply due to couples delaying when they wish to start growing their families.1 Just under 3.6 […]
WHO Prequalifies Takeda’s Qdenga Dengue Vaccine
On May 10, 2024, the World Health Organization (WHO) granted prequalification status to the Qdenga (TAK-003) dengue vaccine, developed by Takeda Pharmaceutical Company Ltd. of Tokyo, Japan. The live attenuated virus vaccine is recommended to be given in two doses three months apart to children six to 16 years old living in areas where dengue […]